Henry T. Quach

1.1k total citations · 1 hit paper
12 papers, 625 citations indexed

About

Henry T. Quach is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Henry T. Quach has authored 12 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Henry T. Quach's work include Cancer Immunotherapy and Biomarkers (8 papers), Melanoma and MAPK Pathways (4 papers) and CAR-T cell therapy research (3 papers). Henry T. Quach is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Melanoma and MAPK Pathways (4 papers) and CAR-T cell therapy research (3 papers). Henry T. Quach collaborates with scholars based in United States, China and France. Henry T. Quach's co-authors include Douglas B. Johnson, Javid J. Moslehi, Justin M. Balko, Anna K. Dewan, Andrew L. Mammen, Ali Manouchehri, Bénédicte Lebrun‐Vignes, Alexandra M. Haugh, Joe‐Elie Salem and Fei Ye and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of the American Academy of Dermatology.

In The Last Decade

Henry T. Quach

12 papers receiving 619 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

2019 260 citations Douglas B. Johnson, Ali Manouchehri et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry T. Quach United States	8	502	152	91	89	87	12	625
Christina Arce United States	8	228 0.5×	282 1.9×	22 0.2×	86 1.0×	148 1.7×	18	580
Yalan Bi China	16	221 0.4×	146 1.0×	48 0.5×	12 0.1×	163 1.9×	51	718
Marco Siano Switzerland	15	297 0.6×	153 1.0×	48 0.5×	41 0.5×	175 2.0×	43	639
Yongjie Shui China	15	206 0.4×	154 1.0×	50 0.5×	47 0.5×	207 2.4×	32	648
Michel R. Nasr United States	12	167 0.3×	51 0.3×	72 0.8×	97 1.1×	92 1.1×	30	475
Małgorzata Fuksiewicz Poland	14	321 0.6×	70 0.5×	178 2.0×	17 0.2×	170 2.0×	42	620
Meinrad Mannhart Switzerland	9	304 0.6×	132 0.9×	39 0.4×	34 0.4×	45 0.5×	19	413
Marwan Yared United States	12	176 0.4×	53 0.3×	85 0.9×	73 0.8×	103 1.2×	20	523

Countries citing papers authored by Henry T. Quach

Since Specialization

Citations

This map shows the geographic impact of Henry T. Quach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry T. Quach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry T. Quach more than expected).

Fields of papers citing papers by Henry T. Quach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry T. Quach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry T. Quach. The network helps show where Henry T. Quach may publish in the future.

Co-authorship network of co-authors of Henry T. Quach

This figure shows the co-authorship network connecting the top 25 collaborators of Henry T. Quach. A scholar is included among the top collaborators of Henry T. Quach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry T. Quach. Henry T. Quach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Quach, Henry T., Douglas B. Johnson, Nicole R. LeBoeuf, Jeffrey P. Zwerner, & Anna K. Dewan. (2021). Cutaneous adverse events caused by immune checkpoint inhibitors. Journal of the American Academy of Dermatology. 85(4). 956–966. 92 indexed citations

Bai, Xue, Alexander N. Shoushtari, Allison Betof Warner, et al.. (2021). Discrepancies in response and immune-related adverse events (irAE) of anti-PD-1 monotherapy between races and primary sites in patients (pts) with advanced nonacral cutaneous melanoma (NACM).. Journal of Clinical Oncology. 39(15_suppl). 9530–9530. 1 indexed citations

Patrinely, James R., Arissa Young, Henry T. Quach, et al.. (2020). Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand. European Journal of Cancer. 135. 211–220. 44 indexed citations

Bai, Xue, Henry T. Quach, Christopher Cann, et al.. (2020). Heterogeneous response and irAE patterns in advanced melanoma patients treated with anti-PD-1 monotherapy from different ethnic groups: Subtype distribution discrepancy and beyond.. Journal of Clinical Oncology. 38(15_suppl). 10020–10020. 2 indexed citations

Young, Arissa, Henry T. Quach, Haocan Song, et al.. (2020). Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e000821–e000821. 73 indexed citations

Johnson, Douglas B., Ali Manouchehri, Alexandra M. Haugh, et al.. (2019). Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. Journal for ImmunoTherapy of Cancer. 7(1). 134–134. 260 indexed citations breakdown →

Quach, Henry T., et al.. (2019). Health care utilization and steroid‐refractory toxicities from immune checkpoint inhibitors. Cancer. 126(2). 322–328. 14 indexed citations

Quach, Henry T., et al.. (2019). Integrating Specialty-Specific Clinical Anatomy Education into the Post-Clerkship Curriculum. Medical Science Educator. 30(1). 487–497. 5 indexed citations

Young, Arissa, Henry T. Quach, Elizabeth J. Davis, et al.. (2019). Impact of body composition on outcomes from anti-programmed death-1 (PD-1) treatment.. Journal of Clinical Oncology. 37(15_suppl). 9516–9516. 7 indexed citations

10.

Quach, Henry T., Anna K. Dewan, Elizabeth J. Davis, et al.. (2019). Association of Anti–Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma. JAMA Oncology. 5(6). 906–906. 87 indexed citations

11.

Quach, Henry T., Charles T. Robbins, Justin M. Balko, et al.. (2019). Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy. The Oncologist. 24(7). 872–876. 33 indexed citations

12.

Quach, Henry T., Adam J. Esbenshade, Zhiguo Zhao, & Ritu Banerjee. (2019). Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime. Pediatric Blood & Cancer. 66(7). e27750–e27750. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact